Creative Biolabs-Immuno-oncology

Anti-DNAJB2 (clone 2EC9Q) SynExpress pL-R-P-X Modified CD8+ T cells (CAT#: ITS-1224-CR2169)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNAJB2 (clone 2EC9Q). We employs the HBV (pL-RFP-PAX-XbaI) vector components and the SynExpress system of the Introns Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DNAJB2
Clone
2EC9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pL
Effector Gene
PAX
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.